Osiris Therapeutics, Inc.’s (OSIR) share price has entered into oversold territory with a stochastic value of 17.9012. The Zacks Consensus Estimate on the company’s loss for year ending December 2013 decreased by 5 cents over the past two months to a loss of 34 cents per share. Osiris Therapeutics, Inc. is a Zacks #1 Rank (“Strong Buy”) company.
OSIRIS THERAPTC (OSIR): Free Stock Analysis Report
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment